Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000551.4(VHL):c.263G>A (p.Trp88Ter)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA020197

182978 (ClinVar)

Gene: VHL

Condition: von Hippel-Lindau disease

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: eb3883a6-80f5-45f8-9c0f-a2928a4e24ca

Approved on: 2024-06-25

Published on: 2024-07-17

HGVS expressions

NM_000551.4:c.263G>A

NM_000551.4(VHL):c.263G>A (p.Trp88Ter)

NC_000003.12:g.10142110G>A

CM000665.2:g.10142110G>A

NC_000003.11:g.10183794G>A

CM000665.1:g.10183794G>A

NC_000003.10:g.10158794G>A

NG_008212.3:g.5476G>A

ENST00000696142.1:c.263G>A

ENST00000696143.1:c.263G>A

ENST00000696153.1:c.263G>A

ENST00000256474.3:c.263G>A

ENST00000256474.2:c.263G>A

ENST00000345392.2:c.263G>A

NM_000551.3:c.263G>A

NM_198156.2:c.263G>A

NM_001354723.1:c.263G>A

NM_001354723.2:c.263G>A

NM_198156.3:c.263G>A

Pathogenic

PM2_Supporting PS4 PVS1

Evidence Links 0

Expert Panel

VHL VCEP

Criteria Specification Information

Criteria Specification: ClinGen VHL Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for VHL Version 1.0.0

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

VHL VCEP

The variant NM_000551.4(VHL):c.263G>A (p.Trp88Ter) in VHL is a truncating variant. This variant causes a premature stop codon in a biologically-relevant-exon predicted to undergo nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant has been identified in at least 9 unrelated probands (and other related family members not counted within each) all meeting Danish VHL criteria, from literature evaluated in both CIViC and Hypothes.is VHL datasets. CIViC EIDs (https://civicdb.org): 8292;7606;5776;9374;6806;6538. This corresponds to Strong evidence (5-15 probands) (PS4). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal-dominant von Hippel Lindau syndrome (VHL syndrome) based on the ACMG/AMP criteria applied, as specified by the ClinGen VHL VCEP Version 1.0 (Specifications approval date: 02/26/2024. Variant Approval Date 06/25/2024).

PM2_Supporting

This variant is absent from gnomAD v4.1.0 (PM2_Supporting).

PS4

This variant has been identified in at least 9 unrelated probands (and other related family members not counted within each) all meeting Danish VHL criteria, from literature evaluated in both CIViC and Hypothes.is VHL datasets. CIViC EIDs (https://civicdb.org): 8292;7606;5776;9374;6806;6538. This corresponds to Strong evidence (5-15 probands) (PS4).

PVS1

This variant causes a premature stop codon in a biologically-relevant-exon, predicted to cause nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.